Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences
Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences / Mazzoni F., Petreni P., Perna M., Scotti V., Bongiolatti S., Livi L., Di Costanzo F., Voltolini L.. - In: TUMORI. - ISSN 0300-8916. - ELETTRONICO. - 104:(2018), pp. NP5-NP9-NP9. [10.1177/0300891618775204]
Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences
Voltolini L.
2018
Abstract
Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
